• A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III) OPEN ENROLLMENT
• A Multicenter, Double-blind, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis OPEN ENROLLMENT
• A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis OPEN ENROLLMENT
• A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome –the AEGIS-II Study OPEN ENROLLMENT
• AMG 423 20110203: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced Ejection Fraction OPEN ENROLLMENT
• A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function OPEN ENROLLMENT
• A3921133 Phase 3B/4 Randomized Safety Endpoint Study of 2 Doses of Taofacitinib in Comparison to a Tumor Necrosis Factor (TNF) Inhibitor in Subjects with Rheumatoid Arthritis OPEN ENROLLMENT
• An open-label extension trial to assess the long term safety of nintedanib in patients with "Systemic Sclerosis associated Interstitial Lung Disease" (SSC-ILD) OPEN ENROLLMENT
• COBRA 2015-01 Randomized Trial of Cobra PzF Stenting to Reduce Duration of Triple Therapy (COBRA-REDUCE) OPEN ENROLLMENT
• Envisage